Browsing byAuthorKulasinghe, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 30  next >
Issue DateTitleAuthor(s)
2023Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA.Yaghoubi Naei, V; Bordhan, P; Mirakhorli, F; Khorrami, M; Shrestha, J; Nazari, H; Kulasinghe, A; Ebrahimi Warkiani, M
2020-01Application of microfluidic technology in cancer research and therapy.Azadi, S; Aboulkheyr Es, H; Kulasinghe, A; Bordhan, P; Ebrahimi Warkiani, M
2020-11-03Circulating tumour cell clusters: Insights into tumour dissemination and metastasis.Herath, S; Razavi Bazaz, S; Monkman, J; Ebrahimi Warkiani, M; Richard, D; O'Byrne, K; Kulasinghe, A
2023-01-01Circulating Tumour Cell Isolation and Molecular Profiling; Potential Therapeutic InterventionRadfar, P; Es, HA; Kulasinghe, A; Thiery, JP; Warkiani, ME
2022Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update.Kapeleris, J; Ebrahimi Warkiani, M; Kulasinghe, A; Vela, I; Kenny, L; Ladwa, R; O'Byrne, K; Punyadeera, C
2018-12-01A Collective Route to Head and Neck Cancer MetastasisKulasinghe, A; Schmidt, H; Perry, C; Whitfield, B; Kenny, L; Nelson, C; Warkiani, ME; Punyadeera, C
2023Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.Sadeghirad, H; Liu, N; Monkman, J; Ma, N; Cheikh, BB; Jhaveri, N; Tan, CW; Warkiani, ME; Adams, MN; Nguyen, Q; Ladwa, R; Braubach, O; O'Byrne, K; Davis, M; Hughes, BGM; Kulasinghe, A
2021Emerging role of circulating tumor cells in immunotherapy.Rzhevskiy, A; Kapitannikova, A; Malinina, P; Volovetsky, A; Aboulkheyr Es, H; Kulasinghe, A; Thiery, JP; Maslennikova, A; Zvyagin, AV; Ebrahimi Warkiani, M
2020-10-26Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic.Hanaei, S; Takian, A; Majdzadeh, R; Maboloc, CR; Grossmann, I; Gomes, O; Milosevic, M; Gupta, M; Shamshirsaz, AA; Harbi, A; Burhan, AM; Uddin, LQ; Kulasinghe, A; Lam, C-M; Ramakrishna, S; Alavi, A; Nouwen, JL; Dorigo, T; Schreiber, M; Abraham, A; Shelkovaya, N; Krysztofiak, W; Ebrahimi Warkiani, M; Sellke, F; Ogino, S; Barba, FJ; Brand, S; Vasconcelos, C; Salunke, DB; Rezaei, N
2017-02-15Enrichment of circulating head and neck tumour cells using spiral microfluidic technologyKulasinghe, A; Tran, THP; Blick, T; O'Byrne, K; Thompson, EW; Warkiani, ME; Nelson, C; Kenny, L; Punyadeera, C
2020-10Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer.Kapeleris, J; Kulasinghe, A; Warkiani, ME; Oleary, C; Vela, I; Leo, P; Sternes, P; O'Byrne, K; Punyadeera, C
2020-11-27High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC).Monkman, J; Taheri, T; Ebrahimi Warkiani, M; O'Leary, C; Ladwa, R; Richard, D; O'Byrne, K; Kulasinghe, A
2021<i>IFI27</i> transcription is an early predictor for COVID-19 outcomes; a multi-cohort observational studyShojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Rossi, GR; McCulloch, T; Nalos, M; Chew, KY; Zhu, Y; Xia, Y; Wells, T; Senegaglia, AC; Rebelatto, CLK; Franck, CL; dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, T; Kuan, WS; Jee, Y; Iredell, J; O’Byrne, K; Fraser, J; Davis, M; Belz, G; Warkiani, M; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, K; Tang, B
2022IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study.Shojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Teo, SM; Rodrigues Rossi, G; McCulloch, TR; Nalos, M; Raei, M; Razavi, A; Ghasemian, R; Gheibi, M; Roozbeh, F; Sly, PD; Spann, KM; Chew, KY; Zhu, Y; Xia, Y; Wells, TJ; Senegaglia, AC; Kuniyoshi, CL; Franck, CL; Dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, TM; Kuan, WS; Jee, Y; Iredell, J; O'Byrne, K; Fraser, JF; Davis, MJ; Belz, GT; Warkiani, ME; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, KR; Tang, B
2023-02Immunotherapeutic targets in non-small cell lung cancer.Sadeghirad, H; Bahrami, T; Layeghi, SM; Yousefi, H; Rezaei, M; Hosseini-Fard, SR; Radfar, P; Warkiani, ME; O'Byrne, K; Kulasinghe, A
2021-06-03Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot StudyBark, JM; Kulasinghe, A; Hartel, G; Leo, P; Warkiani, ME; Jeffree, RL; Chua, B; Day, BW; Punyadeera, C
2017-05-16PD-L1 expressing circulating tumour cells in head and neck cancersKulasinghe, A; Perry, C; Kenny, L; Warkiani, ME; Nelson, C; Punyadeera, C
2019-03-18Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets.Kulasinghe, A; Kapeleris, J; Cooper, C; Warkiani, ME; O'Byrne, K; Punyadeera, C
2018-08-14The prognostic role of circulating tumor cells (CTCs) in lung cancerKapeleris, J; Kulasinghe, A; Warkiani, ME; Vela, I; Kenny, L; O'Byrne, K; Punyadeera, C
2016-09-13Short term ex-vivo expansion of circulating head and neck tumour cells.Kulasinghe, A; Perry, C; Warkiani, ME; Blick, T; Davies, A; O'Byrne, K; Thompson, EW; Nelson, CC; Vela, I; Punyadeera, C